Title : Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma.

Pub. Date : 2018 Nov

PMID : 30178114






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Changes in plasma interleukin-8 and tumor necrosis factor-alpha levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma. Sorafenib C-X-C motif chemokine ligand 8 Homo sapiens
2 CONCLUSIONS: Changes in plasma interleukin-8 and TNF-alpha levels during the first few days could predict the response to sorafenib therapy in HCC patients. Sorafenib C-X-C motif chemokine ligand 8 Homo sapiens